Psychemedics Corporation
PMD was delisted on the 12th of December, 2024.
25 hedge funds and large institutions have $11M invested in Psychemedics Corporation in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
0% more funds holding
Funds holding: 25 → 25 (0)
4% less capital invested
Capital invested by funds: $11.4M → $11M (-$439K)
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
Top Sellers
| 1 |
Renaissance Technologies
New York
|
-$217K |
| 2 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$41.1K |
| 3 |
HWM
HighMark Wealth Management
St. Paul,
Minnesota
|
-$24.8K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$16.6K |
| 5 |
BlackRock
New York
|
-$15.4K |
PMD Hedge Fund Activity: Q1 2022 in Review
25 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q1 2022, worth a combined $11M — down 3.8% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PMD positions and 1 closed out — a net gain of 1 holder — while 7 added to existing stakes and 8 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $84.3K. The largest seller was Renaissance Technologies, cutting an estimated $217K.
- 25 institutional investors held Psychemedics Corporation (PMD) as of Q1 2022, unchanged from Q4 2021.
- Funds reported $11M of Psychemedics Corporation stock for Q1 2022, down 3.8% quarter-over-quarter.
- 2 funds opened new Psychemedics Corporation positions in Q1 2022 and 1 closed out, a net change of +1 holder.
- The largest Psychemedics Corporation buyer in Q1 2022 was Susquehanna International Group, an estimated $84.3K added.
- The largest Psychemedics Corporation seller in Q1 2022 was Renaissance Technologies, an estimated $217K sold.
Based on aggregated 13F filings for Q1 2022.